-+ 0.00%
-+ 0.00%
-+ 0.00%

ALKERMES ANNOUNCES INITIATION OF VIBRANCE-3 PHASE 2 STUDY EVALUATING ALKS 2680 FOR THE TREATMENT OF IDIOPATHIC HYPERSOMNIA

Reuters·04/01/2025 11:00:12

Please log in to view news